1.6.01: JP Morgan H&Q 19th Healthcare Conference Issue
Five leading analysts and top management from eighty-seven sector firms examine the Healthcare Industry in this special 319-page JP Morgan H&Q 19th Healthcare Conference issue from The Wall Street Transcript.

    Online subscribers to the Healthcare sector also get
    Biotechnology Industry Issue & Dain Rauscher Wessels Healthcare & Life Sciences 2000 Conference

  1. Health Services Companies - In an in-depth (3,900 words) Analyst Interview, Lori Price, Managing Director at Chase H&Q, examines the outlook for the sector, looking at both the hospital and the managed care sectors, and shares specific stock recommendations.
  2. Life Sciences Technology Companies - In an in-depth (2,300 words) Analyst Interview, Robert Olan, Leading Analyst at Chase H&Q, examines the outlook for the sector, discussing the performance of the life sciences technology companies over the last 12 months, and shares specific stock recommendations.
  3. Pharmaceutical Services - In an in-depth (3,800 words) Analyst Interview, Ken Miller, Leading Analyst at Chase H&Q, examines the outlook for the sector, explaining the investment analysis process, and shares specific stock recommendations.
  4. Specialty Pharmaceutical Stocks - In an in-depth (2,900 words) Analyst Interview, Corey Davis, Leading Analyst at Chase H&Q, examines the outlook for the sector, explaining the attraction for specialty pharma stocks, and shares specific stock recommendations.
  5. Large-Cap Pharmaceutical Stocks - In an in-depth (2,500 words) Analyst Interview, Carl Seiden, Managing Director with JP Morgan, examines the outlook for the sector, looking at the performance of the large-cap pharma stocks and shares specific stock recommendations.
  6. CEO interviews (average 2,500 words). Top management of eighty-seven sector firms examine the outlook for their firm and the sector. Firms include:
    3-Dimensional Pharmaceuticals, Abgenix, Accredo Health, Albany Molecular Research, American Medical Systems, Amylin Pharmaceuticals, Angiotech Pharmaceuticals, AtheroGenics, Biacore International, Biogen, Caliper Technologies, Caremark Rx, Celgene, Chronimed, CollaGenex Pharmaceuticals, DIANON Systems, Discovery Partners International, Diversa, dj Orthopedics, DURECT, Edwards Lifesciences, Emisphere Technologies, EPIX Medical, Esperion Therapeutics, First Horizon Pharmaceutical, Gemini Genomics, Genaissance Pharmaceuticals, Gene Logic, Genometrix, Genomic Solutions, Genzyme Biosurgery, Genzyme General, HCA-The Healthcare Company, HealthCentral.com, HEALTHSOUTH, Human Genome Sciences, Humana, Illumina, Inspire Pharmaceuticals, Landacorp, Large Scale Biology, LifePoint Hospitals, McKesson HBOC, Matrix Pharmaceutical, Medarex, MediChem Life Sciences, Medicines Company, Medicis Pharmaceutical, MedQuist, Medsite, Microcide Pharmaceuticals, MiniMed, Molecular Devices, Neose Technologies, Nexell Therapeutics, NovaMed Eyecare, NPS Pharmaceuticals, Orthofix International NV, Packard BioScience Company, PAREXEL International, Pharsight, PRAECIS PHARMACEUTICALS, QIAGEN, Rambus, SangStat Medical, Skila, SpectRx, Structural GenomiX, Sunesis Pharmaceuticals, Symphonix Devices, Symyx Technologies, Syrrx, Targeted Genetics, Telik, TLC Laser Eye Center, Trigon Healthcare, Tularik, Universal Health Services, Valentis, VARIAGENICS, Versicor, Vertex Pharmaceuticals, Vion Pharmaceuticals, Vyyo, Welch Allyn, WellPoint Health Networks, Xenon Genetics
    7. ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us
    For immediate access online - click here to gain a password.
     
    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
          		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 
     

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

     

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.

Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE